Formulation science and pharmaceutical process development for recombinant proteins, ADCs, cytotoxics and live‑virus vaccines, including high‑concentration formulations, lyophilization, fill/finish and downstream process development. Targets biopharma developers with scalable tech transfer to GMP, cost‑effective manufacturing processes, regulatory‑ready development reports and dedicated GMO S2/BSL‑2 safety labs.